The Duke Cancer Institute has announced a reconfiguration of its National Cancer Institute-Designated Research Programs effective January 1, 2021. 

The Mike Slive Foundation has awarded a grant to Ming Chen, PhD to test whether the induction of ferroptosis can help slow the growth of neuroendocrine prostate cancer in preclinical animal models and to determine how it works.

Elizabeth N. Pavlisko, MD has been selected as a Duke Clinical Leadership Program (DCLP) Fellow. 

"The Pathology Report" our 2020 Fall Newsletter, is ready for you. Check it out on Issuu to read and download.

Jung Wook Park, PhD, holder of the endowed Rollie Assistant Professorship in Correlative Pathology, was named recently as one of 27 recipients nationwide of the Class of 2020 Young Investigator Award from the Prostate Cancer Foundation (PCF).

I am very pleased to appoint Ken H. Young, MD PhD, as Chief of Hematopathology Division and DCI Blood Cancer Pathology Service, effective January 1, 2021.

Laura Barisoni, MD, co-director of the Division of AI/Computational Pathology and newly appointed Director of the Renal Pathology Service in the Department of Pathology, has dedicated the last decade of her professional life in implementing digital pathology and image analysis to study kidney diseases.

Elizabeth Pavlisko, MD has been promoted to the rank of Associate Professor Pathology.

Duke Pathology is engaged in a statewide initiative to analyze COVID-19 specimens, to advance understandings of the mechanisms of the virus and help to find a cure.

I am very pleased to announce that Xiaoyin “Sara” Jiang, MD, FCAP, has been appointed Chief of the Head and Neck Pathology Service.